Trazodone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

View at publisher Summarise with VIRAT
Authors: Sebastián Malleza
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

After completing this activity, participants should be able to: Differentiate the dose-dependent pharmacodynamic effects of trazodone at hypnotic doses (25-100 mg) versus antidepressant doses (150-600 mg) and explain how receptor interactions at 5-HT2A, α1-adrenergic, and histamine H1 receptors contribute to its clinical effects and adverse events. Evaluate the safety profile of trazodone in special populations, including assessment of priapism risk factors in male patients, QT prolongation risk in cardiac patients, fall risk in elderly patients, and appropriate monitoring parameters for drug interactions involving CYP3A4. Apply evidence-based prescribing strategies for trazodone in clinical practice, distinguishing between its FDA-approved use for major depressive disorder and off-label use for insomnia, while incorporating current guideline recommendations and comparative effectiveness data versus other hypnotics.

Fields of Study & Subjects

Treatment of Major Depression Sleep and related disorders Pharmacogenetics and Drug Metabolism

Publication details

Publication date
14 January 2026
Language
EN